Nexperia takes Wingtech to court over alleged rival chip supply chain in China

This is a corporate divorce with geopolitical fault lines. Wingtech's 2020 acquisition of Nexperia for roughly $7 billion has collapsed into a $2 billion counter-claim — not a routine IP dispute, but a structural rupture. The core issue: Wingtech is replicating Nexperia's discrete and power-management product lines domestically, building a parallel production ecosystem that hollows out the Dutch entity's competitive moat and customer exclusivity. Technically, automotive-grade MOSFETs and power ICs carry 18-to-24-month qualification cycles. A bifurcated production line forces downstream Tier-1 suppliers into dual-sourcing confusion, cross-contamination risk, and costly re-qualification. Strategically, Infineon and STMicroelectronics are watching closely. If Nexperia's China operations are functionally decoupled, European automotive OEMs face supply-continuity exposure, while domestic players like Yangjie and Sanan absorb a de facto technology transfer. Over the next 12-to-24 months, expect a corporate split. The $2 billion figure is a negotiating lever, not a recoverable sum. The real cost is precedent: the risk premium on EU-China semiconductor cross-border M&A will be systematically repriced. This case will outlive the litigation itself.